Ciltacabtagene Autoleucel, A Bcma-Directed Car-T Cell Therapy, In Patients With Relapsed/Refractory Multiple Myeloma: 2-Year Post Lpi Results From The Phase 1B/2 Cartitude-1 Study
Ciltacabtagene Autoleucel
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Ciltacabtagene Autoleucel, A Bcma-Directed Car-T Cell Therapy, In Patients With Relapsed/Refractory Multiple Myeloma: 2-Year Post Lpi Results From The Phase 1B/2 Cartitude-1 Study ### Output: Ciltacabtagene Autoleucel